Article
Development and Validation of an 8-Gene Signature to Improve Survival Prediction of Colorectal Cancer
10 May 2022
Abstract excerpt
Background: Most prognostic signatures for colorectal cancer (CRC) are developed to predict overall survival (OS). Gene signatures predicting recurrence-free survival (RFS) are rarely reported, and postoperative recurrence results in a poor outcome. Thus, we aim to construct a robust, individualized gene signature that can predict both OS and RFS of CRC patients. Methods: univariate Cox regression analysis and...
Topics
Join the communities discussing this publication.